The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 14, 2024 | BB Biotech AG | 10% Owner | Sell(S) | 1.3M | $0.66 | $845K |
| Sep 27, 2024 | Sanders Corazon (Corsee) D. | Director | Grant(A) | 1K | — | $0 |
| Sep 27, 2024 | Hoffmann Dave | Director | Grant(A) | 1K | — | $0 |
| Sep 27, 2024 | Selick Harold E | Director | Grant(A) | 1K | — | $0 |
| Sep 27, 2024 | Gruia Gabriela | Director | Grant(A) | 1K | — | $0 |
| Sep 27, 2024 | Lalande Kevin M. | Director, 10% Owner | Grant(A) | 1K | — | $0 |
| Apr 2, 2024 | BB Biotech AG | 10% Owner | Buy(P) | 135K | $2.35 | $316K |
| Apr 2, 2024 | BB Biotech AG | 10% Owner | Buy(P) | 769K | $0.13 | $100K |
| Apr 2, 2024 | Biotech Target N V | 10% Owner | Buy(P) | 250K | $2.35 | $588K |
| Apr 2, 2024 | Biotech Target N V | 10% Owner | Buy(P) | 769K | $0.13 | $100K |
| Apr 2, 2024 | Biotech Target N V | 10% Owner | Buy(P) | 135K | $2.35 | $316K |
| Apr 2, 2024 | Lalande Kevin M. | Director, 10% Owner | Grant(A) | 175K | $2.35 | $411K |
| Apr 2, 2024 | Lalande Kevin M. | Director, 10% Owner | Grant(A) | 1.2M | $0.13 | $150K |
| Apr 2, 2024 | Lalande Kevin M. | Director, 10% Owner | Grant(A) | 402K | $2.35 | $945K |
| Jan 23, 2024 | Poma Eric E | See remarks, Director | Grant(A) | 23K | — | $0 |
| Jan 23, 2024 | Kim Jason S. | Chief Financial Officer | Grant(A) | 10K | — | $0 |
| Jan 23, 2024 | Voi Maurizio | Chief Medical Officer | Grant(A) | 10K | — | $0 |
| Oct 31, 2023 | Voi Maurizio | Chief Medical Officer | Grant(A) | 11K | — | $0 |
| Oct 27, 2023 | Gruia Gabriela | Director | Grant(A) | 1K | — | $0 |
| Oct 27, 2023 | Hoffmann Dave | Director | Grant(A) | 1K | — | $0 |
| Oct 27, 2023 | Lalande Kevin M. | Director, 10% Owner | Grant(A) | 1K | — | $0 |
| Oct 27, 2023 | Lanfear Jonathan | Director | Grant(A) | 1K | — | $0 |
| Oct 27, 2023 | Sanders Corazon (Corsee) D. | Director | Grant(A) | 1K | — | $0 |
| Oct 27, 2023 | Selick Harold E | Director | Grant(A) | 1K | — | $0 |
| Aug 31, 2023 | Gruia Gabriela | Interim Chief Medical Officer, Director | Grant(A) | 12K | — | $0 |
| Jul 17, 2023 | BB Biotech AG | 10% Owner | Buy(P) | 4.3M | $0.47 | $2.0M |
| Feb 15, 2023 | Kim Jason S. | See remarks | Grant(A) | 170K | — | $0 |
| Feb 15, 2023 | Waltzman Roger J. | See remarks | Grant(A) | 170K | — | $0 |
| Feb 15, 2023 | Poma Eric E | See remarks, Director | Grant(A) | 400K | — | $0 |
| Jul 7, 2022 | Kim Jason S. | See remarks | Option exercise(M) | 12K | $0.71 | $9K |
| Jul 7, 2022 | Kim Jason S. | See remarks | Option exercise(M) | 12K | — | $0 |
| Jun 16, 2022 | McLennan Sean | See remarks | Buy(P) | 30K | $0.82 | $25K |
| Jun 15, 2022 | Cunningham Joe H | 10% Owner | Buy(P) | 62K | $0.89 | $55K |
| Jun 15, 2022 | Lalande Kevin M. | Director, 10% Owner | Buy(P) | 62K | $0.89 | $55K |
| Jun 14, 2022 | Cunningham Joe H | 10% Owner | Buy(P) | 60K | $0.87 | $52K |
| Jun 14, 2022 | Lalande Kevin M. | Director, 10% Owner | Buy(P) | 60K | $0.87 | $52K |
| Jun 13, 2022 | Cunningham Joe H | 10% Owner | Buy(P) | 100K | $0.91 | $91K |
| Jun 13, 2022 | Lalande Kevin M. | Director, 10% Owner | Buy(P) | 100K | $0.91 | $91K |
| Jun 3, 2022 | Selick Harold E | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2022 | Hirsch David | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2022 | Hoffmann Dave | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2022 | Lalande Kevin M. | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 3, 2022 | Lanfear Jonathan | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2022 | Gruia Gabriela | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2022 | Sanders Corazon (Corsee) D. | Director | Grant(A) | 15K | — | $0 |
| May 16, 2022 | Biotech Target N V | 10% Owner | Buy(P) | 200K | $1.18 | $236K |
| Apr 27, 2022 | Poma Eric E | See remarks, Director | Option exercise(M) | 27K | $0.71 | $19K |
| Apr 27, 2022 | Poma Eric E | See remarks, Director | Option exercise(M) | 7K | $0.71 | $5K |
| Apr 27, 2022 | Poma Eric E | See remarks, Director | Option exercise(M) | 7K | — | $0 |
| Apr 27, 2022 | Poma Eric E | See remarks, Director | Option exercise(M) | 27K | — | $0 |
| Mar 1, 2022 | Gruia Gabriela | Director | Grant(A) | 25K | — | $0 |
| Feb 15, 2022 | Kim Jason S. | See remarks | Grant(A) | 125K | — | $0 |
| Feb 15, 2022 | Poma Eric E | See remarks, Director | Grant(A) | 300K | — | $0 |
| Feb 15, 2022 | McLennan Sean | See remarks | Grant(A) | 85K | — | $0 |
| Feb 15, 2022 | Waltzman Roger J. | See remarks | Grant(A) | 125K | — | $0 |
| Jan 6, 2022 | BB Biotech AG | 10% Owner | Buy(P) | 200K | $4.04 | $808K |
| Sep 21, 2021 | BB Biotech AG | 10% Owner | Buy(P) | 750K | $6.00 | $4.5M |
| Sep 16, 2021 | Biotech Target N V | 10% Owner | Buy(P) | 100K | $6.13 | $613K |
| Jul 27, 2021 | BB Biotech AG | 10% Owner | Buy(P) | 75K | $7.09 | $532K |
| Jul 26, 2021 | BB Biotech AG | 10% Owner | Buy(P) | 80K | $7.00 | $560K |
| Jul 20, 2021 | Biotech Target N V | 10% Owner | Buy(P) | 125K | $7.13 | $891K |
| Jul 19, 2021 | Biotech Target N V | 10% Owner | Buy(P) | 119K | $6.96 | $831K |
| Jul 6, 2021 | Poma Eric E | See remarks, Director | Option exercise(M) | 4K | $0.71 | $3K |
| Jul 6, 2021 | Poma Eric E | See remarks, Director | Option exercise(M) | 4K | — | $0 |
| Jun 28, 2021 | Kim Jason S. | See remarks | Option exercise(M) | 32K | — | $0 |
| Jun 28, 2021 | Kim Jason S. | See remarks | Option exercise(M) | 32K | $0.71 | $23K |
| Jun 28, 2021 | Kim Jason S. | See remarks | Sell(S) | 3K | $8.36 | $23K |
| Jun 3, 2021 | Hoffmann Dave | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2021 | Selick Harold E | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2021 | Morenstein Scott D | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2021 | Sanders Corazon (Corsee) D. | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2021 | Hirsch David | Director | Grant(A) | 15K | — | $0 |
| Jun 3, 2021 | Lalande Kevin M. | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 3, 2021 | Lanfear Jonathan | Director | Grant(A) | 15K | — | $0 |
| Apr 19, 2021 | BB Biotech AG | 10% Owner | Buy(P) | 41K | $8.08 | $330K |
| Apr 15, 2021 | BB Biotech AG | 10% Owner | Buy(P) | 150K | $8.62 | $1.3M |
| Apr 14, 2021 | Biotech Target N V | 10% Owner | Buy(P) | 150K | $8.37 | $1.3M |
| Apr 13, 2021 | Biotech Target N V | 10% Owner | Buy(P) | 100K | $7.81 | $781K |
| Apr 12, 2021 | BB Biotech AG | 10% Owner | Buy(P) | 50K | $8.02 | $401K |
| Apr 9, 2021 | BB Biotech AG | 10% Owner | Buy(P) | 236K | $8.23 | $1.9M |
| Apr 8, 2021 | Biotech Target N V | 10% Owner | Buy(P) | 300K | $8.22 | $2.5M |
| Apr 7, 2021 | Biotech Target N V | 10% Owner | Buy(P) | 200K | $8.24 | $1.6M |
| Apr 5, 2021 | BB Biotech AG | 10% Owner | Buy(P) | 200K | $9.44 | $1.9M |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).